Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial

Santosh B Murthy1, Issam Awad2, Sagi Harnof2

  • 1From the Department of Neurology (S.B.M.) and Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute (S.B.M.), Weill Cornell Medicine, New York, NY; Department of Neurological Surgery (I.A.), University of Chicago Medicine, IL; Department of Neurological Surgery (S.H.), Chaim Sheba, Israel; Department of Neurological Surgery (F.A.), University of Maryland School of Medicine, Baltimore; Department of Neurological Surgery (M.H.), University of Alabama School of Medicine, Birmingham; Department of Neurological Surgery (J.J.), Thomas Jefferson University, Philadelphia, PA; Department of Neurological Surgery (J.-L.C.) and Division of Neurosciences Critical Care, Department of Neurology (L.R.L., W.C.Z.), Johns Hopkins University School of Medicine, Baltimore, MD; Department of Neurological Surgery (J.H.), School of Medicine, University of Texas Health, San Antonio; Department of Neurological Surgery (P.C.), University of Kansas, Kansas City; and Division of Brain Injury Outcomes Center (R.D., N.M., V.E., D.F.H.), Johns Hopkins University, Baltimore, MD. sam9200@med.cornell.edu.

Neurology
|June 30, 2017
PubMed

Insights

Permanent cerebrospinal fluid (CSF) shunting after intraventricular hemorrhage (IVH) is linked to higher CSF output and elevated intracranial pressure. While shunting did not affect mortality, it was associated with poorer functional outcomes in survivors.

Area of Science:

  • Neurosurgery
  • Neurology
  • Critical Care Medicine

Background:

  • Spontaneous intraventricular hemorrhage (IVH) poses significant risks, often necessitating cerebrospinal fluid (CSF) diversion.
  • The need for permanent CSF shunting and its impact on functional outcomes remain critical areas of study.

Purpose of the Study:

  • To investigate factors predicting the need for permanent CSF diversion in patients with spontaneous IVH.
  • To examine the relationship between CSF shunting and functional outcomes, including mortality and neurological recovery.

Main Methods:

  • Analysis of data from the Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III) trial.
  • Multivariate analysis to identify predictors of permanent CSF shunting.
  • Assessment of 180-day mortality and modified Rankin Scale scores.

Main Results:

  • 18% of patients with IVH required permanent CSF shunting.
  • Predictors of shunting included black race, longer external ventricular drainage (EVD) duration, multiple EVD placements, high CSF output, and elevated intracranial pressure (>30 mm Hg).
  • CSF shunting was not associated with 180-day mortality but correlated with poorer functional outcomes in survivors.

Conclusions:

  • Elevated intracranial pressure, high CSF output, and multiple EVD placements are associated with an increased likelihood of permanent CSF shunting in IVH patients.
  • Intraventricular alteplase, early imaging, and CSF measures were not predictive of permanent shunting.
  • Permanent CSF shunting impacts functional recovery in survivors of spontaneous IVH.
Abstract